Evidence map›Paper›PMID 28931850›Full record

ArticleScientific reports2017

Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women.

Beate Ott, Thomas Skurk, Ljiljana Hastreiter, Ilias Lagkouvardos, Sandra Fischer, Janine Büttner, Teresa Kellerer, Thomas Clavel, Michael Rychlik, Dirk Haller and 1 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04044118 nacompletednot on this map

Calorie Restriction Intervention Induces Enterotype-associated BMI Loss in Nonobese Individuals

TypeinterventionalSponsorBGI-ShenzhenRan2017 to 2018Enrolled41ConditionsHealthy VolunteerArmsLow Calorie Diet
NCT05477212 narecruitingnot on this mapstarted 2022, after this paper: background citation

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet on Diagnostic and Prognostic Markers in Liver Disease

TypeinterventionalSponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisRan2022 to 2025Enrolled30ConditionsPermeability, Increased, NAFLD, ObesityArmsKetogenic Diet
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Review
  15. Review
  16. Weight Loss-Associated Remodeling of Adipose Tissue Immunometabolism.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Beate OttElse Kröner-Fresenius-Center of Nutritional Medicine, Technical University of Munich, Freising, Germany.
Thomas SkurkElse Kröner-Fresenius-Center of Nutritional Medicine, Technical University of Munich, Freising, Germany.
Ljiljana HastreiterElse Kröner-Fresenius-Center of Nutritional Medicine, Technical University of Munich, Freising, Germany.
Ilias LagkouvardosZIEL Institute for Food and Health, Technical University of Munich, Freising-Weihenstephan, Germany.ORCID 0000-0001-9337-4033
Sandra FischerZIEL Institute for Food and Health, Technical University of Munich, Freising-Weihenstephan, Germany.
Janine BüttnerCharité-Universitätsmedizin, Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Berlin, Germany.
Teresa KellererElse Kröner-Fresenius-Center of Nutritional Medicine, Technical University of Munich, Freising, Germany.
Thomas ClavelZIEL Institute for Food and Health, Technical University of Munich, Freising-Weihenstephan, Germany.
Michael RychlikChair of Analytical Food Chemistry, Technical University of Munich, Freising, Germany.
Dirk HallerZIEL Institute for Food and Health, Technical University of Munich, Freising-Weihenstephan, Germany.
Hans HaunerElse Kröner-Fresenius-Center of Nutritional Medicine, Technical University of Munich, Freising, Germany. hans.hauner@tum.de.
Fresenius (Germany) · DELeibniz-Institute for Food Systems Biology at the Technical University of Munich · DECharité - Universitätsmedizin Berlin · DETUM Klinikum · DEUniversitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent findings suggest an association between obesity, loss of gut barrier function and changes in microbiota profiles. Our primary objective was to examine the effect of caloric restriction and subsequent weight reduction on gut permeability in obese women. The impact on inflammatory markers and fecal microbiota was also investigated. The 4-week very-low calorie diet (VLCD, 800 kcal/day) induced a mean weight loss of 6.9 ± 1.9 kg accompanied by a reduction in HOMA-IR (Homeostasis model assessment-insulin resistance), fasting plasma glucose and insulin, plasma leptin, and leptin gene expression in subcutaneous adipose tissue. Plasma high-molecular weight adiponectin (HMW adiponectin) was significantly increased after VLCD. Plasma levels of high-sensitivity C-reactive protein (hsCRP) and lipopolysaccharide-binding protein (LBP) were significantly decreased after 28 days of VLCD. Using three different methods, gut paracellular permeability was decreased after VLCD. These changes in clinical parameters were not associated with major consistent changes in dominant bacterial communities in feces. In summary, a 4-week caloric restriction resulted in significant weight loss, improved gut barrier integrity and reduced systemic inflammation in obese women.

Indexed as

Caloric RestrictionGastrointestinal MicrobiomeMicrobiotaPermeabilityAdultBlood Chemical AnalysisFecesFemaleGastrointestinal TractHumansInflammationMiddle AgedObesityTreatment Outcome

Identifiers

PMID28931850
PMCPMC5607294
OpenAlexW2753985003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.